Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes
Nicolas Leventoux,Satoru Morimoto,Mitsuru Ishikawa,Shiho Nakamura,Fumiko Ozawa,Reona Kobayashi,Hirotaka Watanabe,Sopak Supakul,Satoshi Okamoto,Zhi Zhou,Hiroya Kobayashi,Chris Kato,Yoshifumi Hirokawa,Ikuko Aiba,Shinichi Takahashi,Shinsuke Shibata,Masaki Takao,Mari Yoshida,Fumito Endo,Koji Yamanaka,Yasumasa Kokubo,Hideyuki Okano
DOI: https://doi.org/10.1007/s00401-024-02734-w
IF: 15.887
2024-05-17
Acta Neuropathologica
Abstract:Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC), a rare and complex neurological disorder, is predominantly observed in the Western Pacific islands, including regions of Japan, Guam, and Papua. This enigmatic condition continues to capture medical attention due to affected patients displaying symptoms that parallel those seen in either classical amyotrophic lateral sclerosis (ALS) or Parkinson's disease (PD). Distinctly, postmortem examinations of the brains of affected individuals have shown the presence of α-synuclein aggregates and TDP-43, which are hallmarks of PD and classical ALS, respectively. These observations are further complicated by the detection of phosphorylated tau, accentuating the multifaceted proteinopathic nature of ALS/PDC. The etiological foundations of this disease remain undetermined, and genetic investigations have yet to provide conclusive answers. However, emerging evidence has implicated the contribution of astrocytes, pivotal cells for maintaining brain health, to neurodegenerative onset, and likely to play a significant role in the pathogenesis of ALS/PDC. Leveraging advanced induced pluripotent stem cell technology, our team cultivated multiple astrocyte lines to further investigate the Japanese variant of ALS/PDC (Kii ALS/PDC). CHCHD2 emerged as a significantly dysregulated gene when disease astrocytes were compared to healthy controls. Our analyses also revealed imbalances in the activation of specific pathways: those associated with astrocytic cilium dysfunction, known to be involved in neurodegeneration, and those related to major neurological disorders, including classical ALS and PD. Further in-depth examinations revealed abnormalities in the mitochondrial morphology and metabolic processes of the affected astrocytes. A particularly striking observation was the reduced expression of CHCHD2 in the spinal cord, motor cortex, and oculomotor nuclei of patients with Kii ALS/PDC. In summary, our findings suggest a potential reduction in the support Kii ALS/PDC astrocytes provide to neurons, emphasizing the need to explore the role of CHCHD2 in maintaining mitochondrial health and its implications for the disease.
pathology,neurosciences,clinical neurology